Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1908 1
1954 1
1955 1
1959 1
1960 2
1962 2
1965 2
1966 1
1967 1
1968 4
1969 3
1970 1
1971 1
1972 2
1973 1
1974 1
1977 1
1978 2
1980 1
1981 1
1982 1
1984 2
1985 4
1986 2
1987 4
1988 4
1989 4
1990 7
1991 8
1992 10
1993 3
1994 7
1995 10
1996 15
1997 18
1998 11
1999 19
2000 15
2001 5
2002 10
2003 9
2004 3
2005 8
2006 5
2007 3
2008 3
2009 2
2010 4
2011 4
2012 6
2013 3
2015 2
2016 3
2017 2
2018 1
2019 1
2021 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 10520699

245 results
Results by year
Filters applied: . Clear all
Page 1
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Ferrer L, Faivre-Chauvet A, Campion L, Vuillez JP, Devillers A, Chang CH, Goldenberg DM, Chatal JF, Barbet J. Kraeber-Bodéré F, et al. J Nucl Med. 2006 Feb;47(2):247-55. J Nucl Med. 2006. PMID: 16455630 Free article. Clinical Trial.
245 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page